1. Generics Bulletin

New CEO Plans ‘Transformation’ For Jubilant Generics

Follows A Poor Q1 And Further FDA Observations After Roorkee Import Alert

 
• By Dave Wallace

Jubilant Pharmova is planning to transform its generics business with the appointment of a new managing director and CEO, after a difficult period for the unit that saw a tough Q1 amid ongoing difficulties linked to an import alert for its Roorkee manufacturing plant.

Caterpillar to butterfly transformation
Jubilant is hoping to transform its fortunes with new leadership • Source: Shutterstock

Jubilant Pharmova is planning a “transformation” for its generics business after announcing the appointment of Jaidev Rajpal as managing director and CEO of Jubilant Generics from 11 October.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Generics Bulletin